Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
Release Date: February 1, 2015
Last Reviewed: December 11, 2014
Expiration Date: January 31, 2016
Time to Complete Activity:  1.5 hours

*This activity expired for credit on January 31, 2016 and is no longer available for credit
This activity is provided by Global Education Group.  Paradigm Medical Communications, LLC is the educational partner.



Richard B. Lipton, MD
Edwin S. Lowe Professor and Vice Chair of Neurology
Professor, Department of Psychiatry and Behavioral Sciences
Professor, Department of Epidemiology and Population Health
Director, Montefiore Headache Center
Albert Einstein College of Medicine
Bronx, NY
Stephen D. Silberstein, MD, FACP
Director, Jefferson Headache Center
Jefferson Hospital for Neuroscience
Professor, Department of Neurology
Thomas Jefferson University
Philadelphia, PA
Target Audience
This activity has been designed to address the educational needs of neurologists, headache specialists, primary care physicians, and other HCPs who treat patients who suffer from migraine.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Explain the difference between episodic and chronic migraine.
  • Interpret guidelines for providing preventive treatment to appropriate migraine patients.
  • Describe appropriate use of existing and forthcoming therapeutic options for migraine, including proper administration techniques.
Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Credit Designation Statement
Global Education Group designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.
Disclosure of Commercial Support
This activity is supported by an educational grant from Allergan, Inc.
Instructions for Participation
To receive a CME certificate of participation, participants must:
  • Read the entire publication, including the Continuing Medical Education information.
  • Register or log in at www.paradigmmc.com/a318e to complete and submit the online posttest and evaluation OR complete the posttest/evaluation form at the end of the article and mail or fax it to Paradigm Medical Communications, LLC, 523 Route 303, Orangeburg, NY 10962; fax (845) 398-5108.
  • Answer 70% of the posttest questions correctly to earn credit. Online completion of the posttest allows unlimited opportunities to successfully complete the posttest.
Following online completion of the posttest and evaluation, a certificate of participation will be available for download/printing immediately. Participants who submit a posttest/evaluation form via mail or fax will receive an email with a link to their certificate of participation within 1 to 2 weeks following receipt of completed form.
For questions regarding CME credit, contact Paradigm at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
Adobe Reader
This activity is in Adobe Acrobat PDF format. To view the activity, you will need Adobe Reader. If you do not have Adobe Reader installed on your computer, please visit http://get.adobe.com/reader/to install a free version of Adobe Reader.
Supported Browsers:
For Windows: Internet Explorer 7 or higher, Firefox 4.0, Safari 3, Google Chrome, Opera 9.5
For Mac: Safari 3, Firefox 4.0, Google Chrome
Linux: Firefox 4.0
Technical Support: If you have any technical problems, please email us at contactus@paradigmmc.com.
Disclosure and Resolution of Conflict of Interest
Global Education Group (Global) and Paradigm Medical Communications, LLC (Paradigm) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.  All identified conflicts of interest are thoroughly vetted by Global and Paradigm for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter
Reported Financial Relationship
Richard B. Lipton, MD
Grant/Research Support: The National Institutes of Health, etc. paid to Montefiore Medical Center at Albert Einstein College of Medicine
Retained Consultant: Allergan, Inc.; eNeura Inc.; Alder Biopharmaceuticals Inc.; Novartis International AG; Labrys Biologics; CoLucid Pharmaceuticals, Inc.; Merck & Co. Inc.; Johnson & Johnson; Nautilus Pharma; Dr. Reddy's Laboratories Ltd; NuPathe Inc.; Zogenix, Inc.
Honoraria: Cornell; American Academy of Neurology; Alder BioPharmaceuticals Inc.; AHS Compounding Pharmacy; eNeura; Montefiore Medical Center; Merck & Co.; Novartis International AG;SAI Partners; Labrys Biologics Inc.; Zogenix, Inc.
Stock Shareholder: eNeura Inc (Neuralieve)
Stephen D. Silberstein, MD
Grant/Research Support: Allergan, Inc.; Amgen Inc.; Cumberland Pharmaceuticals, Inc.; ElectroCore Medical, Inc.; Labrys Biologics; Eli Lilly and Company; Merz Pharmaceuticals; Troy Healthcare
Retained Consultant/Advisory Panel: Alder Biopharmaceuticals Inc.; Allergan, Inc.; Amgen Inc.; Avanir Pharmaceuticals, Inc.; eNeura; ElectroCore Medical, LLC; Labrys Biologics; Medscape, LLC; Medtronic, Inc.; Neuralieve; NINDS; Pfizer, Inc.; Teva Pharmaceuticals Industries Ltd.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager
Reported Financial Relationship
Ashley Marostica, RN, MSN
Nothing to disclose
Amanda Glazer, PhD
Nothing to disclose
Amanda Jamrogiewicz
Nothing to disclose
Andrea Funk
Nothing to disclose
Paradigm Medical Communications, LLC staff members have no financial conflicts to disclose.
Independent peer reviewer has no financial conflicts to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Paradigm do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty, and do not necessarily represent those of Global Education Group or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global or Paradigm. Global and Paradigm accept no liability for the content referenced in this activity.
Privacy policy
Global and Paradigm are committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Global and Paradigm to continuously improve the learning experience.
Global Education Group and Paradigm Medical Communications, LLC do not transfer, sell, or share personal information with outside parties. Global Education Group and Paradigm will not otherwise disclose personal information unless required to in a legal process. Global and Paradigm staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
© 2015 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.